You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Genentech is months away from starting operations at a new $240 million pharmaceutical-fill/finish plant it recently built in Hillsboro, Ore., designed to accommodate its needs and those of its partner-turned-acquirer, Roche.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Time magazine looks into how liquid biopsies are changing cancer care.
According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.
The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.